Gene design
Serotiny designs genes for next-generation cell and gene therapies.
Source: LinkedIn company description · Retrieved October 13, 2026
Serotiny is a therapeutic discovery company designing genes for next-generation cell and gene therapies.
The company invents therapeutic multi-domain proteins through software, mammalian synthetic biology, and therapeutic expertise. Its discovery platform integrates computationally aided protein design, high-throughput cellular assays, and data-driven analytics.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Serotiny designs genes for next-generation cell and gene therapies.
Source: LinkedIn company description · Retrieved October 13, 2026
Serotiny engineers multi-domain proteins for cell therapies, including Chimeric Antigen Receptors used in CAR-T immunotherapies, and second-generation Cas9-based gene-editing tools such as Base and Prime Editors.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 13, 2026, September 14, 2026, September 15, 2026, September 18, 2026, September 30, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.